Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1681 AL 1695

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects

Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B; NINDS NET-PD Investigators.

J Parkinsons Dis. 2015;5(4):731-6. doi: 10.3233/JPD-150666.

Method development for quantification of the environmental neurotoxin annonacin in Rat plasma by UPLC-MS/MS and application to a pharmacokinetic study

Bonneau N, Schmitz-Afonso I, Brunelle A, Touboul D, Champy P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Nov 1;1004:46-52. doi: 10.1016/j.jchromb.2015.09.039. Epub 2015 Sep 30.

Parkinsonism, small vessel disease, and white matter disease: Is there a link?

Luca CC, Rundek T.

Neurology. 2015 Nov 3;85(18):1532-3. doi: 10.1212/WNL.0000000000002091. Epub 2015 Oct 7.

Interventions for fatigue in Parkinson's disease

Elbers RG, Verhoef J, van Wegen EE, Berendse HW, Kwakkel G.

Cochrane Database Syst Rev. 2015 Oct 8;2015(10):CD010925. doi: 10.1002/14651858.CD010925.pub2.

Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease

Voutilainen MH, Arumäe U, Airavaara M, Saarma M.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3739-48. doi: 10.1016/j.febslet.2015.09.031. Epub 2015 Oct 9.

Parkinson's disease: A risk factor for osteoporosis

Malochet-Guinamand S, Durif F, Thomas T.

Joint Bone Spine. 2015 Dec;82(6):406-10. doi: 10.1016/j.jbspin.2015.03.009. Epub 2015 Oct 6.

Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel

Solla P, Cannas A, Marrosu MG, Marrosu F.

Parkinsonism Relat Disord. 2015 Nov;21(11):1383-4. doi: 10.1016/j.parkreldis.2015.09.039. Epub 2015 Sep 25.

New insight into the therapeutic role of the serotonergic system in Parkinson's disease

Ohno Y, Shimizu S, Tokudome K, Kunisawa N, Sasa M.

Prog Neurobiol. 2015 Nov;134:104-21. doi: 10.1016/j.pneurobio.2015.09.005. Epub 2015 Oct 9.

Brain-gut-microbiota axis in Parkinson's disease

Mulak A, Bonaz B.

World J Gastroenterol. 2015 Oct 7;21(37):10609-20. doi: 10.3748/wjg.v21.i37.10609.

Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis

Rekaik H, Blaudin de Thé FX, Prochiantz A, Fuchs J, Joshi RL.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3786-94. doi: 10.1016/j.febslet.2015.10.002. Epub 2015 Oct 13.

Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis

Combs HL, Folley BS, Berry DT, Segerstrom SC, Han DY, Anderson-Mooney AJ, Walls BD, van Horne C.

Neuropsychol Rev. 2015 Dec;25(4):439-54. doi: 10.1007/s11065-015-9302-0. Epub 2015 Oct 12.

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

Wang Q, Liu Y, Zhou J.

Transl Neurodegener. 2015 Oct 12;4:19. doi: 10.1186/s40035-015-0042-0. eCollection 2015.

Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-Analysis

Gudala K, Kanukula R, Bansal D.

Int J Chronic Dis. 2015;2015:697404. doi: 10.1155/2015/697404. Epub 2015 Feb 3.

Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target

Wellman M, Abizaid A.

eNeuro. 2015 Apr 24;2(2):ENEURO.0053-14.2015. doi: 10.1523/ENEURO.0053-14.2015. eCollection 2015 Mar-Apr.

Type 1 diabetes mellitus and isolated adrenocorticotropin deficiency manifested by parkinsonism: a case report and literature review

Ohara N, Kojima N, Sato T, Ikarashi T, Sone H, Oki Y, Kamoi K, Hara M, Sasaki H.

Intern Med. 2015;54(20):2629-35. doi: 10.2169/internalmedicine.54.5022. Epub 2015 Oct 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias